Variant Summary
- Also known as
- ASP835TYR,RS121913488
- HGVS
- NC_000013.11:g.28018505C>A,NC_000013.10:g.28592642C>A,ENST00000241453.12:c.2503G>T,NM_004119.3:c.2503G>T,ENSP00000241453.7:p.Asp835Tyr,NP_004110.2:p.Asp835Tyr,LRG_457t1:c.2503G>T,NM_004119.2:c.2503G>T
- Variant Type(s)
- missense_variant
- Evidence Items
- 5
Evidence Level Distribution
Level D: 5
Evidence Items
Showing CIViC evidence rows where gene = FLT3 and variant = D835Y.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| D | Predictive | Supports | Sensitivity/Response | Leukemia | Lestaurtinib | 4 |
| D | Predictive | Supports | Sensitivity/Response | Cancer | Gilteritinib | 4 |
| D | Predictive | Supports | Sensitivity/Response | Cancer | FLT3 Tyrosine Kinase Inhibitor TTT-3002,Midostaurin,Lestaurtinib,Crenolanib | 3 |
| D | Predictive | Does Not Support | Sensitivity/Response | Cancer | Ponatinib,AG1295,AGS324,Linifanib,Quizartinib,Sunitinib,Sorafenib,R406,KW2449 | 3 |
| D | Predictive | Supports | Sensitivity/Response | Acute Myeloid Leukemia | Gilteritinib | 2 |